Search
By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.
Learn about 14 students who will receive doctoral degrees from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at MSK.
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
In this Q&A, Memorial Sloan Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.
Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research.
Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Take a look back at some of the biggest cancer science stories from this past year.
Approaches used for research into the social lives of bacteria can also be used to explore how tumors behave and evolve.
In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.